BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1678946)

  • 1. Effects of a cholecystokinin receptor antagonist on rat exocrine pancreatic response to raw soya flour.
    Sundaram S; Dayan AD
    Hum Exp Toxicol; 1991 May; 10(3):179-82. PubMed ID: 1678946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic atrophy in rats produced by the cholecystokinin-A receptor antagonist devazepide.
    Nylander AG; Chen D; Ihse I; Rehfeld JF; Håkanson R
    Scand J Gastroenterol; 1992 Sep; 27(9):743-7. PubMed ID: 1411279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic blood flow in the rat during enlargement, involution, and cholecystokinin treatment.
    Oates PS; Bruce NW; Morgan RG
    Am J Physiol; 1984 Nov; 247(5 Pt 1):G457-62. PubMed ID: 6541882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of cholecystokinin in cholestyramine-induced changes of the exocrine pancreas.
    Koop I; Lindenthal M; Schade M; Trautmann M; Adler G; Arnold R
    Pancreas; 1991 Sep; 6(5):564-70. PubMed ID: 1946314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-course of the pancreatic changes following long-term stimulation or inhibition of the CCK-A receptor.
    Ohlsson B; Axelson J; Sternby B; Rehfeld JF; Ihse I
    Int J Pancreatol; 1995 Aug; 18(1):59-66. PubMed ID: 7594771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholecystokinin is responsible for growth of the pancreas after pancreaticobiliary diversion in rats.
    Gasslander T; Axelson J; Håkanson R; Ihse I; Lilja I; Rehfeld JF
    Scand J Gastroenterol; 1990 Oct; 25(10):1060-5. PubMed ID: 2263879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of L-364,718, a new cholecystokinin receptor antagonist, on camostate-induced growth of the rat pancreas.
    Wisner JR; McLaughlin RE; Rich KA; Ozawa S; Renner IG
    Gastroenterology; 1988 Jan; 94(1):109-13. PubMed ID: 3335282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the CCK receptor antagonist L364,718 on pancreatic growth in adult and developing animals.
    Zucker KA; Adrian TE; Bilchik AJ; Modlin IM
    Am J Physiol; 1989 Oct; 257(4 Pt 1):G511-6. PubMed ID: 2478030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of antagonist of receptors for gastrin, cholecystokinin and bombesin on growth of gastroduodenal mucosa and pancreas.
    Dembiński A; Warzecha Z; Konturek SJ; Banas M; Cai RZ; Schally AV
    J Physiol Pharmacol; 1991 Sep; 42(3):263-77. PubMed ID: 1665365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of CCK antagonist L-364,718, pancreastatin (33-49) and a somatostatin analogue on camostate-induced rat pancreatic hypertrophy.
    Schmidt WE; Stöckmann F; Choudhury AR; Wilms HM; Siegel EG; Nustede R; Fölsch UR; Creutzfeldt W
    Digestion; 1989; 44(2):105-16. PubMed ID: 2612749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic polyamine concentrations and cholecystokinin plasma levels in rats after feeding raw or heat-inactivated soybean flour.
    Löser C; Fölsch UR; Mustroph D; Cantor P; Wunderlich U; Creutzfeldt W
    Pancreas; 1988; 3(3):285-91. PubMed ID: 3387422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of high fat diet and cholecystokinin receptor blockade on pancreatic growth and tumor initiation in the hamster.
    Herrington MK; Permert J; Kazakoff KR; Pour PM; Zuker KA; Bilchik AJ; Adrian TE
    Carcinogenesis; 1993 May; 14(5):1021-6. PubMed ID: 7684953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous cholecystokinin, the major factor responsible for dietary protein-induced pancreatic growth.
    Morisset J; Guan D; Jurkowska G; Rivard N; Green GM
    Pancreas; 1992; 7(5):522-9. PubMed ID: 1381095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose effects of raw soybean flour on pancreatic growth.
    Morgan RG; Crass RA; Oates PS
    Adv Exp Med Biol; 1986; 199():81-9. PubMed ID: 2432760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic administration of a potent cholecystokinin receptor antagonist, L-364,718, fails to inhibit pancreas growth in preweanling rats.
    Wisner JR; Ozawa S; Xue BG; Renner IG
    Pancreas; 1990 Jul; 5(4):434-8. PubMed ID: 1696382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of peptide YY on CCK/CCK antagonist interactions in cerulein-induced pancreatic injury.
    Tito JM; Rudnicki M; Robinson DC; Guiney WB; Adrian TE; Gold MS
    Ann N Y Acad Sci; 1995 May; 757():410-2. PubMed ID: 7541974
    [No Abstract]   [Full Text] [Related]  

  • 17. Cell death (apoptosis) during pancreatic involution after raw soya flour feeding in the rat.
    Oates PS; Morgan RG; Light AM
    Am J Physiol; 1986 Jan; 250(1 Pt 1):G9-14. PubMed ID: 2417499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cholecystokinin antagonist L-364,718 inhibits the action of cholecystokinin but not bombesin on rat pancreatic secretion in vivo.
    Anderson L; Dockray GJ
    Eur J Pharmacol; 1988 Feb; 146(2-3):307-11. PubMed ID: 3371402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of CCK and its analogues in the organogenesis of the fetal rat pancreas.
    Feurle GE; Hamscher G; Firat AE
    Pancreas; 1995 Apr; 10(3):281-6. PubMed ID: 7624305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous cholecystokinin release responsible for pancreatic growth observed after pancreatic juice diversion.
    Rivard N; Guan D; Maouyo D; Grondin G; Bérubé FL; Morisset J
    Endocrinology; 1991 Dec; 129(6):2867-74. PubMed ID: 1954873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.